SYA dark blue font on white background (1).jpg
Custom Research Presented at AMIA Informatics Summit Reveals Promising Findings for Healthcare Innovation
March 14, 2023 08:05 ET | Syapse
SAN FRANCISCO, March 14, 2023 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care,...
Syneos Health_rgb_r.jpg
Syneos Health Adds HUB Patient Suite to Deployment Solutions Business
October 27, 2022 07:30 ET | Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it is introducing a dedicated...
Setareh Williams
Setareh Williams Joins Cobbs Creek Healthcare as Managing Partner/Head of Real-World Evidence and Scientific Communications
May 04, 2022 09:00 ET | Cobbs Creek Healthcare
Newtown Square PA, May 04, 2022 (GLOBE NEWSWIRE) -- Cobbs Creek Healthcare, a data science and advanced analytics firm transforming healthcare decision-making through innovative insights and a...
Roots-Analysis-Logo.png
The real world evidence (RWE) market is projected to be worth USD 4.5 billion by 2030, growing at a CAGR of 15%, claims Roots Analysis
March 03, 2021 08:45 ET | Roots Analysis
London, March 03, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Pharmaceutical and Life Sciences Real World Evidence Market, (2nd Edition), 2021-2030” report to its list of...
Syneos Health and ConcertAI Announce Strategic Collaboration to Accelerate the Use of Real World Evidence and AI to Advance Oncology Research
December 03, 2020 08:49 ET | Syneos Health, Inc.
BOSTON and MORRISVILLE, N.C., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization and ConcertAI, the leader in oncology...
logo big square.png
Syapse Announces Research Collaboration with the FDA Focused on the Regulatory Use of Real-World Evidence
August 14, 2019 06:00 ET | Syapse
SAN FRANCISCO, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Syapse and the U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) have signed a multi-year Research Collaboration Agreement...